about
Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chainsThe crystal structure of human CD1b with a bound bacterial glycolipidImmune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infectionThe actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.Phage display-derived recombinant antibodies with TCR-like specificity against alpha-galactosylceramide and its analogues in complex with human CD1d molecules.Essential role for autophagy during invariant NKT cell development.Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cellsDiverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activationSaposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation.Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors.Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.The Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone To Direct Human TLR7 into Endosomes.Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes.Binding strength and dynamics of invariant natural killer cell T cell receptor/CD1d-glycosphingolipid interaction on living cells by single molecule force spectroscopy.High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine productionNon-glycosidic compounds can stimulate both human and mouse iNKT cells.Modulation of single channels underlying hippocampal L-type current enhancement by agonists depends on the permeant ion.The crystal structure of human CD1d with and without alpha-galactosylceramide.Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection.Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.Clinician Panel Recommendations for Use of Negative Pressure Wound Therapy with Instillation.Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cellsPlasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesionsStructure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains
P50
Q24301525-36F7D9CF-97D2-485F-BF9E-9D0516E94FA5Q24307448-355C90A8-6556-4C98-91E2-687004499DA9Q24795912-5517BB11-8509-4359-9C12-D20E321C8A68Q27319157-B0E22F4B-9761-4EDC-BAC3-8B3FC193ECBFQ27646628-906C7F95-5D18-4A7B-8FD6-9348E30CB480Q33318487-0AE184B5-3CF4-4D7D-995C-67CDEF526074Q34831651-863DC597-C89F-420E-B719-859CB21E169FQ35153216-7BE09D2D-C011-4773-9CFE-80A016995662Q35195374-B848D46B-54E9-4BCA-8396-67A7C0246CFBQ36228456-CC90106C-7D91-48F3-92AC-970A725B286AQ36288508-283D0CBE-3AB9-42D8-ABAF-12C7304BA03FQ36300047-D6C27225-7FDC-4921-97FB-8B883BC3046FQ37377504-6A2DF382-178C-4F55-ACFE-345F6B54C94CQ37588791-B34040B6-2632-40FF-9B9E-47B46084F6D5Q38734317-154D39AA-9B27-4867-8342-CC81CFCFB842Q38881784-C159436E-0F5B-4F34-A398-68EB9C149178Q39076945-D649B40A-5BF7-439A-8629-A21F26A1D120Q39567442-2C53D2A7-AEC6-4727-AD7A-BEBA01185B37Q39882299-AB4C7167-B06D-432B-A875-C78FFAEEA34AQ39892288-926CABE6-FD35-4AE8-8D03-64219016CCD1Q40136032-29D5D5F0-8236-47EA-A729-7A1933C4B482Q40618967-53D36A22-F693-445A-8572-8CA3716F7118Q42257577-793D9F68-6FCF-41C3-8ECC-3ED1ACD8432FQ42608724-379EF853-25EE-422E-81D1-37AFB4840A23Q42623865-C96F81D0-E853-4B47-97CF-4F3C833EC7E8Q42661990-05698B20-C099-4F04-902A-BD08C89A066CQ45413329-A6317F90-76EC-4182-BEEB-AAAED4B660BCQ46614223-FE3E3024-B882-419C-BA31-1DFC557F9926Q51611058-FD31D7C9-6D1C-4A7D-8316-08A7231EB7C5Q53134858-C23CED3A-E637-4E0E-894F-C517A1B5FF98Q57220164-D0E97248-A52C-42E6-ACE4-CABE01A0F10FQ57265377-6504CDED-6186-49CD-8A87-1E8E4826FD91Q60311710-F67556A7-A3B6-46B4-8B1E-D25059994FA6
P50
name
Dawn Shepherd
@ast
Dawn Shepherd
@en
Dawn Shepherd
@es
Dawn Shepherd
@nl
type
label
Dawn Shepherd
@ast
Dawn Shepherd
@en
Dawn Shepherd
@es
Dawn Shepherd
@nl
prefLabel
Dawn Shepherd
@ast
Dawn Shepherd
@en
Dawn Shepherd
@es
Dawn Shepherd
@nl